Resmed Inc (NYSE:RMD)
| 218.39 Delayed Data As of Sep 30 |  -0.07 / -0.03%Today’s Change | 189.40 Today|||52-Week Range 275.66 | -16.16% Year-to-Date |
Latest RMD News | Press Releases
| ResMed (RMD) Gains on Product Uptake Even as Expenses Rise Sep 26 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 218.46 |
| Today’s open | 219.26 |
| Day’s range | 218.32 - 223.11 |
| Volume | 521,200 |
| Average volume (3 months) | 522,366 |
| Market cap | $32.0B |
Data as of 4:02pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | +63.42% |
| Earnings growth (this year) | +12.63% |
| Earnings growth (next 5 years) | +11.56% |
| Revenue growth (last year) | +11.93% |
| P/E ratio | 41.2 |
| Price/Sales | 8.61 |
| Price/Book | 9.51 |
Competitors
Data as of 4:02pm ET, 09/30/2022
Financials
| Next reporting date | October 27, 2022 |
| EPS forecast (this quarter) | $1.52 |
| Annual revenue (last year) | $3.6B |
| Annual profit (last year) | $779.4M |
| Net profit margin | 21.78% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
